Contact Details
Proactive UK Ltd
+44 20 7989 0813
Oxford Cannabinoid Technologies: Phase 1 approval for lead chronic pain drug
May 24, 2023 at 10:59 AM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|